Projects

Building India's biggest cGMP vaccine facility | NNE

Based on NNE’s facility design, HLL Biotech Limited is building a major vaccine R&D and production plant. Read about India’s largest vaccine project ever.

Projects

Qualification and validation of GMP vaccine facility

Find out how NNE’s qualification and validation team helped GSK Biologicals’ build a new GMP vaccine plant in time to meet seasonal production demands.

Projects

Lifecycle support in vaccine facility expansion

Read the story about NNE’s long-term commitment in the expansion of Sanofi Pasteur’s GMP manufacturing facility for vaccines in Shenzhen, China.

Projects

cGMP facility revamp secures fast vaccine supply | NNE

Read how NNE helped Bavarian Nordic transform an existing pharma production building into a qualified vaccine production cGMP facility in just 11 months.

TechTalk

How was the PDA Annual Meeting? Vaccines, aseptic processing and GMP updates

Rapid vaccination development a game-changer for the pharma industry Covid-19 and the subsequent global vaccination effort brought aseptic manufacturing and Advanced Therapeutic Medicinal Products (ATMPs) to the forefront of people’s minds. However, the rapid research, development, approval and production of Covid-19 vaccines in 2020 and 2021 shows just how much can be achieved in just one year. Stronger collaboration between the pharma indust...

Careers

Working for NNE in USA | NNE

Amid the current COVID-19 pandemic, our team is working to support accelerated vaccine production as well as design facilities that can generate the vaccines in large quantities.

TechTalk

How can new GMP regulations inspire and improve biosafety? | TechTalk

Finally, a fully closed and automated filling isolator could be used for large-scale vaccine manufacturing for medium and high containment. However, even with primary containment, the main part of the vaccine segment still poses a biorisk.

Projects

24/7 service cleanroom for personalized medicine

Its responsibilities include also translational and clinical research on cellular-based cancer vaccines that are tested in patients with malignant melanoma, glioblastoma, prostate cancer, lymphomas and ovarian cancer.

TechTalk

High containment, high reward with single-use | TechTalk

This is valid for, for example, for vaccine development at pilot scale as well as in full-scale manufacturing facilities Single-use systems and risk considerations in biocontainment settings Let’s clear the air around single-use systems: they are not a catch-all for your efficiency and speed-to-market needs.

There's so much to love about the pharma engineering industry

I have worked with a lot of different processes and products, from insulin to monoclonal antibodies and vaccines .